ADVANCED ENZYME TECHNOLOGIES
|
|
BOM : 540025     NSE : ADVENZYMES     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Mar 10,2025 |
Price(EOD): ₹ 283.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 3,169.57 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ADVANCED ENZYME TECHNOLOGIES | 6.7% | -17.5% | -23.9% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -7.5% | 2.3% |
DIVIS LABORATORIES | -0.2% | -9.9% | 60.4% |
CIPLA | 4.4% | -0.6% | -1% |
TORRENT PHARMACEUTICALS | 4.8% | -2.9% | 15.4% |
DR REDDYS LABORATORIES | NA | -9.4% | -10.2% |
MANKIND PHARMA | -0.7% | -8.8% | 7.1% |
ZYDUS LIFESCIENCES | 2.5% | -11.4% | -5.5% |
LUPIN | 2.9% | -8.1% | 20.9% |
FUNDAMENTAL ANALYSIS OF ADVANCED ENZYME TECHNOLOGIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ADVANCED ENZYME TECHNOLOGIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
23.11
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 137.12 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 2.4
P/B Calculated based on Book Value of Rs 1,321.10 Cr
[Latest Year - Mar2024 - Consolidated Results ] 5.05
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 627.55 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
3% -14% -19% |
SHARE PRICE MOMENTUM OF ADVANCED ENZYME TECHNOLOGIES
ADVANCED ENZYME TECHNOLOGIES vs SENSEX
DEBT OF ADVANCED ENZYME TECHNOLOGIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
0.02 0.01 0.01 0.01 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ADVANCED ENZYME TECHNOLOGIES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ADVANCED ENZYME TECHNOLOGIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
15.75% 30.27% 25.62% 16.42% |
5.08% 2.77% -9.95% -8.53% |
QtrlyTrend |
4 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
ADVANCED ENZYME TECHNOLOGIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE SMALLCAP | 4.4% | -11.6% | -1.9% |
BSE ALLCAP | 3.1% | -6.1% | -0.2% |
BSE MIDSMALLCAP | 3% | -10.5% | -1.8% |
BSE HEALTHCARE | 2.2% | -9% | 12.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MICROCAP 250 | 6.7% | -8.7% | 1.4% |
NIFTY TOTAL MARKET | 3% | -6% | 0.1% |
You may also like the below Video Courses
FAQ about ADVANCED ENZYME TECHNOLOGIES
Is ADVANCED ENZYME TECHNOLOGIES good for long term investment?
As on Mar 10,2025, the Fundamentals of ADVANCED ENZYME TECHNOLOGIES look Strong and hence it may be good for long term investment! See Financial Performance of ADVANCED ENZYME TECHNOLOGIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ADVANCED ENZYME TECHNOLOGIES UnderValued or OverValued?
As on Mar 10,2025, ADVANCED ENZYME TECHNOLOGIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of ADVANCED ENZYME TECHNOLOGIES ?
As on Mar 10,2025, the Intrinsic Value of ADVANCED ENZYME TECHNOLOGIES is Rs. 328.72 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 274.31
Fair Value [Median EV / Sales Model] : Rs. 328.72
Fair Value [Median Price / Sales Model] : Rs. 350.33
Estimated Median Fair Value of ADVANCED ENZYME TECHNOLOGIES : Rs. 328.72
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.